Canid Company Profile
Canid, founded in 2020 and headquartered in Manhattan, is a privately held, venture capital-backed healthcare technology company with 47 employees that develops a healthcare dashboard and process tool to simplify vaccination record management by automating workflows, securing vaccine margins, and managing inventory for state officials and pediatric practitioners, having raised $13.4 million in a Series A1 funding round as of June 2025 from 15 investors.
Overview
- Year Founded: 2020
- Status: Private
- Employees: 47
- Latest Deal Type: Series A1
- Latest Deal Amount: $13.4M
- Investors: 15
General Information
Canid is a developer of a healthcare dashboard and process tool designed to simplify vaccination record management. The tool offers administrative consulting, secures vaccine margins, automates vaccine workflow, and oversees vaccine inventory, enabling state officials and pediatric practitioners to focus on their day-to-day practice.
Contact Information
- Website: www.canid.io
- Corporate Office: 215 East 24th Street, Suite 315, Manhattan, New York, NY 10010, United States
Ownership and Financing Status
- Ownership Status: Privately Held (backing)
- Financing Status: Venture Capital-Backed
Primary Industry
- Practice Management (Healthcare)
- Other Industries: Other Healthcare Technology Systems
- Verticals: Digital Health, HealthTech
Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Status | Stage |
|---|---|---|---|---|---|
| Early Stage VC (Series A1) | 03-Jun-2025 | $13.4M | Completed | Generating Revenue | |
| Early Stage VC (Series A) | 21-Sep-2023 | Completed | Generating Revenue | ||
| Early Stage VC (Series A) | 01-Jul-2022 | $500K | $1.5M | Completed | Generating Revenue |
| Early Stage VC (Series A) | 12-Mar-2021 | $1M | $1M | Completed | Generating Revenue |
Cap Table (Partial)
| Stock | # of Shares Authorized | Par Value | Original Issue Price | Liquidation | Pref. Multiple | Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|
| Series A-3 | 751,124 | $0.000100 | $0.91 | $0.91 | 1x | $0.91 | 7.49% |
| Series A-2 | 1,409,729 | $0.000100 | $0.71 | $0.71 | 1x | $0.71 | 14.05% |
Competitors
- VaxCare (Private Equity-Backed, Orlando, FL)
- Color (Venture Capital-Backed, Burlingame, CA)
Investors (Partial List)
- OnDeck (Corporation)
- Telescope Partners (Growth/Expansion)
- Angel (individual)
- MKT1 (Venture Capital)
FAQs
When was Canid founded?
Canid was founded in 2020.
Where is Canid headquartered?
Canid is headquartered in New York, NY.
What is the size of Canid?
Canid has 47 total employees.
What industry is Canid in?
Canid’s primary industry is Practice Management (Healthcare).
Is Canid a private or public company?
Canid is a Private company.
How much funding has Canid raised over time?
Canid has raised $16.4M.
Who are Canid’s investors?
OnDeck, Telescope Partners, MKT1, and others are among the 15 investors who have invested in Canid.
Who are Canid’s competitors?
VaxCare and Color are competitors of Canid.